2-[(4-Methylbenzoyl)amino]ethyl 4-methylbenzoate, 97.0%, 1g

1,1,1,3,3,3-esafluoro-2-propanolo (HFIP), 10 ml, >=99%, per la sintesi di peptidi

(R)-Oxetan-2-ylmethanol, 97%, 1g

2-(3-Methylbenzoyl)-6-methylpyridine, 97.0%, 1g

4-(Difluoromethoxy)benzenesulfonamide>98.0%(HPLC)(N)5g

O-Methyl-L-tyrosine>98.0%(HPLC)(T)1g

3-(2,3-Dimethoxyphenyl)-3-oxo-propionic acidethyl ester, 1g

z-asp(otbu)-osu, 95.0%, 1g

5-(4-Bromo-benzyl)-3-cyclopropyl-[1,2,4]oxadiazole, 95.0%, 1g

3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one, 98%, 50mg

Oxan-4-yl(phenyl)methanol, 97%, 100mg

(R)-4-Nitrophenyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate, 95.0%, 5g

1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[(1E)-2-(trimethylsilyl)ethenyl]-, 95%, 2.5g